综述的目的急性肝衰竭对于既往正常人来说是致命性的综合征。
Purpose of review Acute liver failure (ALF) is a devastating syndrome afflicting previously healthy individuals.
目的：阐明急性肝衰竭时门脉高压的发生与肠源性内毒素血症和肝内微循环障碍的关系。
AIM: to observe the relationship among acute portal hypertension, intestinal endotoxemia and hepatic microcirculatory disturbance.
方法回顾性分析8例接受急诊肝移植治疗的急性肝衰竭患者的临床资料，总结急性肝衰竭实施肝移植的经验。
Methods A retrospective review was undertaken on the clinical data of 8 patients undergoing emergency liver transplantation for ALT.
脂肪性肝病恶化后会很复杂，最严重的是非酒精性脂肪肝炎、肝纤维化、肝硬化。非酒精性脂肪肝会导致肝功能衰竭。
Fatty liver disease can take many forms that vary in severity, with the most severe being nonalcoholic steatohepatitis (NASH), fibrosis and cirrhosis. NAFLD can lead to liver failure.
非酒精性脂肪肝会导致肝功能衰竭。
急性肝功能衰竭可导致肝性脑病。
这是因为考虑到患者耐受性的因素，如果患者的耐受性差，患者发生肝衰竭的可能性将增加。
This is because if you do tolerability is very poor and you even see the increased incidence of liver failure.
目的：观察teca型组合型人工肝支持系统(HALSS)治疗急性肝功能衰竭(alf)患者的有效性和安全性。
Objective: to assess the efficacy and safety of type TECA hybrid artificial liver support system (HALSS) to treat patients with acute liver failure (ALF).
但是当肝功能衰竭患者合并水肿时是否可以使用白蛋白，许多临床医生存在疑虑，担心诱发肝性脑病。
But when patients of hepatic failure are complicated with edema, many doctors suspect whether albumin can be used for edema. They are afraid that albumin could cause hepatic encephalopathy.
MARS是一项补救性的治疗法，对于肝肾衰竭患者的安全性良好；
The MARS system is a salvage treatment with a good safety profile for patients with both liver and kidney failure.
方法：1、临床研究：采用前瞻性对照研究的方式，选择64位肝衰竭患者(辨证属气阴两虚者)，随机分为2组，每组各32人。
Method: 1 Clinical study: By the way of retrospective controlled study, we chose 64 patients who were weakness of Qi and Yin, divided into 2 groups, 32 for each group.
本组未发生不可逆性肝肾功能衰竭致死亡。
本组未发生不可逆性肝肾功能衰竭致死亡。
应用推荐